KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Sales (2016 - 2025)

Historic Return on Sales for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to 0.34%.

  • Eli Lilly's Return on Sales rose 200.0% to 0.34% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.32%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.32% for FY2025, which is 800.0% up from last year.
  • As of Q4 2025, Eli Lilly's Return on Sales stood at 0.34%, which was up 200.0% from 0.32% recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Return on Sales peaked at 0.36% during Q2 2025, and registered a low of 0.01% during Q3 2023.
  • Over the past 5 years, Eli Lilly's median Return on Sales value was 0.22% (recorded in 2021), while the average stood at 0.22%.
  • Per our database at Business Quant, Eli Lilly's Return on Sales plummeted by -2200bps in 2023 and then surged by 2300bps in 2025.
  • Eli Lilly's Return on Sales (Quarter) stood at 0.22% in 2021, then increased by 23bps to 0.27% in 2022, then dropped by -12bps to 0.23% in 2023, then surged by 39bps to 0.33% in 2024, then grew by 6bps to 0.34% in 2025.
  • Its last three reported values are 0.34% in Q4 2025, 0.32% for Q3 2025, and 0.36% during Q2 2025.